CINECA IRIS Institutional Research Information System

SALIZZONI, Mauro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9371
EU - Europa 7059
AS - Asia 4033
SA - Sud America 173
AF - Africa 94
OC - Oceania 67
Continente sconosciuto - Info sul continente non disponibili 14
Totale 20811
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9131
CN - Cina 2660
IT - Italia 1429
IE - Irlanda 902
FR - Francia 764
DE - Germania 670
SE - Svezia 643
UA - Ucraina 600
KR - Corea 564
FI - Finlandia 476
GB - Regno Unito 354
AT - Austria 325
PL - Polonia 252
JP - Giappone 210
CA - Canada 201
BE - Belgio 149
VN - Vietnam 143
IN - India 124
ES - Italia 99
NL - Olanda 88
TR - Turchia 84
AU - Australia 62
BR - Brasile 62
DK - Danimarca 62
AR - Argentina 53
TW - Taiwan 51
RU - Federazione Russa 49
PT - Portogallo 33
CO - Colombia 31
MX - Messico 31
UZ - Uzbekistan 30
RO - Romania 26
CH - Svizzera 24
EG - Egitto 24
HK - Hong Kong 24
PH - Filippine 23
TH - Thailandia 22
GR - Grecia 21
KE - Kenya 21
HU - Ungheria 20
IR - Iran 19
ID - Indonesia 16
PE - Perù 16
CZ - Repubblica Ceca 14
NO - Norvegia 14
SG - Singapore 14
EU - Europa 13
HR - Croazia 13
SA - Arabia Saudita 10
CL - Cile 8
IL - Israele 8
SN - Senegal 8
ZM - Zambia 8
BG - Bulgaria 6
PK - Pakistan 6
ZA - Sudafrica 6
BA - Bosnia-Erzegovina 5
CM - Camerun 5
NZ - Nuova Zelanda 5
MN - Mongolia 4
MY - Malesia 4
NI - Nicaragua 4
RS - Serbia 4
SI - Slovenia 4
TN - Tunisia 4
CY - Cipro 3
EE - Estonia 3
ET - Etiopia 3
MM - Myanmar 3
MV - Maldive 3
MZ - Mozambico 3
SK - Slovacchia (Repubblica Slovacca) 3
BF - Burkina Faso 2
BY - Bielorussia 2
CR - Costa Rica 2
GM - Gambi 2
KZ - Kazakistan 2
LT - Lituania 2
MD - Moldavia 2
NG - Nigeria 2
NP - Nepal 2
A1 - ???statistics.table.value.countryCode.A1??? 1
BD - Bangladesh 1
CU - Cuba 1
EC - Ecuador 1
GT - Guatemala 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LY - Libia 1
MA - Marocco 1
MU - Mauritius 1
NA - Namibia 1
PS - Palestinian Territory 1
SD - Sudan 1
UG - Uganda 1
UY - Uruguay 1
VE - Venezuela 1
Totale 20811
Salva come PNG Salva come JPEG
Città #
Beijing 1576
Chandler 1384
Dublin 900
Ann Arbor 739
Houston 536
Fairfield 521
Villeurbanne 435
Jacksonville 412
Dearborn 376
Princeton 362
Medford 359
Wilmington 331
Torino 328
Woodbridge 320
Vienna 309
Nyköping 256
Warsaw 233
Redwood City 209
Ashburn 193
Cambridge 187
Seattle 159
Fremont 146
Milan 140
Pisa 139
Shanghai 110
Brussels 97
Guangzhou 97
Hangzhou 92
Boston 89
Nanjing 78
Dong Ket 73
Turin 69
Toronto 66
Boardman 61
Ottawa 54
Verona 54
Hefei 49
Wuhan 49
Chengdu 48
Norwalk 44
Rome 43
Falls Church 41
Tokyo 37
Kunming 34
Lachine 34
San Mateo 34
Chongqing 33
Taipei 32
Zhengzhou 32
London 28
San Diego 28
Düsseldorf 26
Nanchang 26
Fuzhou 24
Paris 24
Rochester 23
Berlin 21
Silver Spring 21
Chicago 20
Changsha 18
Hebei 18
Mountain View 18
Changchun 17
Seoul 17
Jinan 16
Rotterdam 16
São Paulo 16
Barcelona 15
Buenos Aires 15
Hanover 15
Istanbul 15
Malatya 15
Melbourne 15
Padova 15
Phoenix 15
Duncan 14
Lima 14
Philadelphia 14
Strasbourg 14
Tianjin 14
Los Angeles 13
New York 13
Shenyang 13
Auburn Hills 12
Bologna 12
Gent 12
Heidelberg 12
Jakarta 12
Piemonte 12
Xian 12
Atlanta 11
Delhi 11
Nürnberg 11
Upper Marlboro 11
Chennai 10
Leawood 10
Mumbai 10
Nanning 10
New Delhi 10
Ankara 9
Totale 12793
Salva come PNG Salva come JPEG
Nome #
Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial 791
Quantitation of HBV cccDNA in anti-HBc-positive liver donors by droplet digital PCR: A new tool to detect occult infection 742
Liver graft preconditioning, preservation and reconditioning 475
Microvesicles derived from endothelial progenitor cells enhance neoangiogenesis of human pancreatic islets. 458
Liver transplantation for aHUS: still needed in the eculizumab era? 391
Surgical management of post-cholecystectomy bile duct injuries: referral patterns and factors influencing early and long-term outcome 358
The genomic landscape of response to EGFR blockade in colorectal cancer 320
Simultaneous Liver-Kidney Transplantation in Adults: A Single-center Experience Comparing Results with Isolated Liver Transplantation 311
Impact of viral eradication with sofosbuvir-based therapy on the outcome of post-transplant hepatitis C with severe fibrosis 292
Extracellular Vesicles from Human Liver Stem Cells Reduce Injury in an Ex Vivo Normothermic Hypoxic Rat Liver Perfusion Model 258
Prediction of occult hepatitis B virus infection in liver transplant donors through hepatitis B virus blood markers. 237
The role of interventional radiology in the treatment of biliary strictures after paediatric liver transplantation 231
Genetic mutations in primary malignant melanoma of the esophagus: case report and literature review 228
Favorable short-term outcome of hepatitis C virus–positive liver graft with bridging fibrosis: A plea for very early viral eradication 217
A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the Liver Match study 209
Liver transplantation after severe hepatic trauma: a sustainable practice. A single-center experience and review of the literature 208
Genetic and expression analysis of MET, MACC1 and HGF in metastatic colorectal cancer: Response to Met inhibition in patient xenografts and pathological correlations 183
Liver transplantation for symptomatic centrohepatic biliary cystadenoma 175
Isolation, Characterization and Potential Role in Beta Cell-Endothelium Cross-Talk of Extracellular Vesicles Released from Human Pancreatic Islets 172
Minimization of anti-hepatitis B surface antigen immunoglobulins for prophylaxis of hepatitis B viral recurrence in the first month after liver transplantation: the meaning of HBsAg quantitative level at the time of transplant 171
Successful Sequential Liver and Hematopoietic Stem Cell Transplantation in a Child with CD40 Ligand Deficiency and Cryptosporidium -Induced Liver Cirrhosis 160
Donor CYP3A5 genotype influences tacrolimus disposition on the first day after paediatric liver transplantation 154
Human Liver Stem Cell-Derived Microvesicles Inhibit Hepatoma Growth in SCID Mice By Delivering Anti-tumor microRNAs. 152
Anti-angiogenic and immunomodulatory effects of rapamycin on pancreatic islet endothelial cells: relevance for islets engraftment after transplantation 151
RANK OF SURVIVAL BENEFIT, AS A PROPOSED PRIORITY SYSTEM, IN LIVER TRANSPLANT WAITING LIST: EVIDENCES FROM AN ITALIAN MULTICENTRE COHORT STUDY 147
Can the Rank of Survival Benefit Be Used as a Priority Allocation System in an European Liver Transplant Waiting List? Evidences from an Italian Multicentre Cohort Study 145
Left-sided portal hypertension: successful management by laparoscopic splenectomy following splenic artery embolization. 139
Early reduced liver graft survival in hepatitis C recipients identified by two combined genetic markers 137
The Angiogenic Potential of Adipose Mesenchymal Stem Cell-derived Extracellular Vesicles is modulated by Basic Fibroblast Growth Factor 134
Reperfusion damage to the bile canaliculi in transplanted human liver. 131
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients. 131
Normothermic Machine Perfusion of Donor Livers Without the Need for Human Blood Products 125
Liver transplantation for “mass-forming” sclerosing cholangitis after laparoscopic cholecystectomy 123
Extracellular vesicles from human liver stem cells restore argininosuccinate synthase deficiency 120
Risk factors for metabolic syndrome after liver transplantation: what has changed over time 114
AISF position paper on HCV in immunocompromised patients 109
SOFOSBUVIR PLUS RIBAVIRIN IN PATIENTS WITH SEVERE HCV RECURRENCE AFTER LIVER TRANSPLANTATION: A SINGLE CENTRE EXPERIENCE 107
Liver transplantation with cavo-portal hemi-transposition: report of a case with venous pressure measurements 106
Hypothermic Oxygenated Machine Perfusion of Liver Grafts from Brain-Dead Donors 104
ALL ORAL SOFOSBUVIR-BASED ANTIVIRAL THERAPY IN LIVER TRANSPLANT RECIPIENTS AFFECTED BY MODERATE-SEVERE HEPATITIS C RECURRENCE: PREDICTORS OF VIRAL RESPONSE AND SURVIVAL 103
Intrahepatic Administration of Human Liver Stem Cells in Infants with Inherited Neonatal-Onset Hyperammonemia: A Phase I Study 103
Posthepatectomy liver failure after simultaneous versus staged resection of colorectal cancer and synchronous hepatic metastases 101
Bilimetria esofago-gastrica delle 24 ore con BILITEC 2000 98
Prevention of hepatitis C recurrence by bridging sofosbuvir/ribavirin from pre- to post-liver transplant: A real-life strategy 98
Inflammatory bowel disease course in liver transplant versus non-liver transplant patients for primary sclerosing cholangitis: LIVIBD, an IG-IBD study 97
SOFOSBUVIR PLUS RIBAVIRIN BEFORE OR ACROSS LIVER TRANSPLANTATION TO PREVENT HCV RECURRENCE: A SINGLE CENTRE EXPERIENCE 96
Centenarian Livers: Very Long-Term outcomes of very old grafts 96
Endoscopic insertion of 248 prostheses in inoperable carcinoma of the esophagus and cardia: short-term and long-term results. 94
Negativization of viremia prior to liver transplant reduces early allograft dysfunction in hepatitis C recipients 94
[Isolated rupture of the azygos vein caused by contusive thoracic trauma] 93
Carbapenemase Producing Klebsiella Pneumoniae Infection in Liver Transplant Recipients: Review of Our Experience 93
Transplantation of the liver from a HBcAb positive donor into a HCV-RNA positive recipient adversely affects graft survival and worsens the course of HCV recurrence 92
Peri-hepatic gauze packing for the control of haemorrhage during liver transplantation: A retrospective study 91
FEASIBILITY AND EFFICACY OF SOFOSBUVIR-BASED ANTIVIRAL THERAPY BEFORE LIVER TRANSPLANTATION TO PREVENT HCV RECURRENCE: A MONOCENTRIC EXPERIENCE 91
The effect of D-MELD on graft survival and course of HCV recurrence in HCV-RNA positive recipients after liver transplantation 90
SOFOSBUVIR PLUS RIBAVIRIN FOR THE TREATMENT OF SEVERE HCV RECURRENCE AFTER LIVER TRANSPLANTATION: PRELIMINARY DATA FROM A SINGLE-CENTRE EXPERIENCE 90
[The role of azygography in the evaluation of the operability of cancer of the thoracic esophagus] 89
Ruolo dell'ecodoppler nello shunt chirurgico "meso-Rex" in caso di cavernoma portale con pervietà residua della branca intraepatica sinistra 89
[Leiomyoma of the lung. Apropos of 5 cases] 88
[Primary hemangiopericytoma of the lung. Presentation of 2 cases] 85
www.D-MELD.com. THE ONLINE PROGNOSTIC CALCULATOR TO OPTIMIZE DONOR-RECIPIENT MATCH 85
Serological characterization of occult HBV infection in liver donors 85
Antiviral Therapy With Sofosbuvir Plus Ribavirin Before Or Across Liver Transplantation To Prevent HCV Recurrence: Preliminary Data from a Single Centre Experience 82
ANTIVIRAL THERAPY WITH SOFOSBUVIR PLUS RIBAVIRIN IN HCV-INFECTED CIRRHOTIC PATIENTS AWAITING LIVER TRANSPLANTATION: PRELIMINARY DATA FROM A SINGLE-CENTRE EXPERIENCE 81
LIVER TRANSPLANTATION IN PATIENTS WITH PREVIOUS NON-HODGKIN LYMPHOMA: REPORT OF A SINGLE CENTRE EXPERIENCE 80
Risk factors for arterial hypertension after liver transplantation 80
DIAGNOSTIC PERFORMANCE OF TRANSIENT ELASTOGRAPHY IN THE ASSESSMENT OF SIGNIFICANT LIVER FIBROSIS IN PAEDIATRIC LIVER TRANSPLANT RECIPIENTS 79
Thromboelastogram changes in the perioperative period of adult living liver donation 78
Oxidative damage in human liver transplantation. 77
SAFETY AND EFFICACY OF SOFOSBUVIR-BASED ANTIVIRAL THERAPY IMMEDIATELY AFTER LIVER TRANSPLANTATION: A MATCHED CASE-CONTROL ANALYSIS 77
[Immediate and long-term results of 248 cases of endoscopic intubation in inoperable neoplasms of the esophagus and cardia] 76
LIVER GRAFT ISCHEMIC PRECONDITIONING: CLINICAL OUTCOMES 3 YEARS AFTER TRANSPLANTATION 76
Peritoneal leukocytoclastic vasculitis as a cause of unexplained persistent ascites after liver transplantation 76
Successful urgent liver retransplantation for donor-transmitted hepatocellular carcinoma 76
Behind D-MELD: The Role of Primary Indication (HCV or HBV) as Significant Covariate in the Outcome Prediction after Liver Transplants 76
Association of cytomegalovirus infections with recurrence of humoral and cellular autoimmunity to islet autoantigens and of type 1 diabetes in a pancreas transplanted patient 75
MULTIMODAL TREATMENT OF HCC IN CIRRHOTIC LIVER, THE ROLE OF SURGERY. THE EXPERIENCE OF THE LIVER TRANSPLANT CENTRE OF TURIN 75
An unusual case of ileal tuberculosis: only ascites at presentation and absence of caseous necrosis and granulomatous inflammation on biopsy. 74
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis 73
Antiangiogenic and immunomodulatory effects of rapamycin on islet endothelium: relevance for islet transplantation 73
Epithelioid haemangioendothelioma of the liver: report of a case submitted to orthotopic liver transplantation. 72
Therapeutical Implications in the Study of Mutation of the CYP3A5*3 in the Matabolism of Tacrolimus in Paediatric Livel Transplantation: the Experience of a Single Medical Centre 72
Liver transplantation with a partial graft is a risk factor for de novo tumors after transplant in the adult population 72
Recurrence of Hepatitis B Infection in Liver Transplant Patients Receiving Long-Term Hepatitis B Immunoglobulin Prophylaxis 72
Effect of perioperative infusion of antioxidants on neutrophil activation during liver transplantation in humans. 71
An unusual inflammatory hepatic lesion 71
Metabolic Syndrome after liver transplantation: have risk factors changed over time? 71
Liver transplantation for patients with HCV-related end-stage liver disease and undetectable HCV-RNA: the Turin Centre experience 71
HCV infection and HLA-DRB1*11 in liver transplantation: a 15 years marriage 70
Stereotactic ablative radiotherapy in the treatment of hepatocellular carcinoma >3 cm 70
ONCE-DAILY PROLONGED-RELEASE TACROLIMUS IN DE-NOVO LIVER TRANSPLANTATION: A CASE MATCH ANALYSIS WITH TWICE-DAILY TACROLIMUS FORMULATION 70
DOES CROSSMATCH IMPACT LIVER TRANSPLANTATION OUTCOME? A SINGLE CENTER EXPERIENCE 70
[Percutaneous biopsy of the lung] 69
Stereotactic ablative radiation therapy prior to liver transplantation in hepatocellular carcinoma 69
ANTIVIRAL THERAPY WITH SOFOSBUVIR PLUS RIBAVIRIN FOR THE TREATMENT OF SEVERE HCV RECURRENCE AFTER LIVER TRANSPLANTATION: PRELIMINARY DATA FROM A SINGLE-CENTRE EXPERIENCE 69
Pharmacokinetics of cyclosporine in recipients of marginal versus standard liver transplants 67
Outcomes of Liver Transplantation in Simultaneously Hepatitis BSurface Antigen and Hepatitis C Virus RNA Positive Recipients: TheDeleterious Effect of Donor Hepatitis B Core Antibody Positivity 67
IMMUNOGENETIC FACTORS AFFECT SURVIVAL IN HCV-INFECTED LIVER TRANSPLANT RECIPIENTS 67
Safety and efficacy of endoscopic retrograde cholangiopancreatography in patients with post-liver transplant biliary complications: results of a cohort study with long-term follow-up 67
Does the Combination between HCV, Presence of Hepatocarcinoma and MELD Influence the Outcome of Liver Transplantation? 66
Totale 13834
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38355
article - articoli 0
book - libri 0
conference - conferenze 10960
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49315
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201899 0000 00 00 00099
2018/20192290 8111625476 167222 108270 98249447202
2019/20203491 168153198363 269611 435234 359289231181
2020/20212545 277169195130 208152 205175 284229209312
2021/20223278 156162174196 224225 248219 130246559739
2022/20234471 571326134405 3461120 420304 4531442480
Totale 21850